Discontinued Administration (6 Months a Year) of Growth Hormone to Children With Very Short Stature and Having Suffered From Intrauterine Growth Retardation: Safety and Effect on Growth of Long-term Therapy
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Somatropin (Primary)
- Indications Growth disorders; Short stature
- Focus Therapeutic Use
- Sponsors Novo Nordisk
Most Recent Events
- 30 Apr 2015 New trial record